Business

FDA panel backs much-debated ALS drug in rare turnaround


WASHINGTON (AP) — A panel of federal health advisers voted Wednesday to recommend approval for an experimental drug to treat Lou Gehrig’s disease, a …

Read more

Show More

Related Articles

Back to top button